Cargando…
The Endogenous Th17 Response in NO(2)-Promoted Allergic Airway Disease Is Dispensable for Airway Hyperresponsiveness and Distinct from Th17 Adoptive Transfer
Severe, glucocorticoid-resistant asthma comprises 5-7% of patients with asthma. IL-17 is a biomarker of severe asthma, and the adoptive transfer of Th17 cells in mice is sufficient to induce glucocorticoid-resistant allergic airway disease. Nitrogen dioxide (NO(2)) is an environmental toxin that cor...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778003/ https://www.ncbi.nlm.nih.gov/pubmed/24069338 http://dx.doi.org/10.1371/journal.pone.0074730 |
_version_ | 1782285054129471488 |
---|---|
author | Martin, Rebecca A. Ather, Jennifer L. Daggett, Rebecca Hoyt, Laura Alcorn, John F. Suratt, Benjamin T. Weiss, Daniel J. Lundblad, Lennart K. A. Poynter, Matthew E. |
author_facet | Martin, Rebecca A. Ather, Jennifer L. Daggett, Rebecca Hoyt, Laura Alcorn, John F. Suratt, Benjamin T. Weiss, Daniel J. Lundblad, Lennart K. A. Poynter, Matthew E. |
author_sort | Martin, Rebecca A. |
collection | PubMed |
description | Severe, glucocorticoid-resistant asthma comprises 5-7% of patients with asthma. IL-17 is a biomarker of severe asthma, and the adoptive transfer of Th17 cells in mice is sufficient to induce glucocorticoid-resistant allergic airway disease. Nitrogen dioxide (NO(2)) is an environmental toxin that correlates with asthma severity, exacerbation, and risk of adverse outcomes. Mice that are allergically sensitized to the antigen ovalbumin by exposure to NO(2) exhibit a mixed Th2/Th17 adaptive immune response and eosinophil and neutrophil recruitment to the airway following antigen challenge, a phenotype reminiscent of severe clinical asthma. Because IL-1 receptor (IL-1R) signaling is critical in the generation of the Th17 response in vivo, we hypothesized that the IL-1R/Th17 axis contributes to pulmonary inflammation and airway hyperresponsiveness (AHR) in NO(2)-promoted allergic airway disease and manifests in glucocorticoid-resistant cytokine production. IL-17A neutralization at the time of antigen challenge or genetic deficiency in IL-1R resulted in decreased neutrophil recruitment to the airway following antigen challenge but did not protect against the development of AHR. Instead, IL-1R-/- mice developed exacerbated AHR compared to WT mice. Lung cells from NO(2)-allergically inflamed mice that were treated in vitro with dexamethasone (Dex) during antigen restimulation exhibited reduced Th17 cytokine production, whereas Th17 cytokine production by lung cells from recipient mice of in vitro Th17-polarized OTII T-cells was resistant to Dex. These results demonstrate that the IL-1R/Th17 axis does not contribute to AHR development in NO(2)-promoted allergic airway disease, that Th17 adoptive transfer does not necessarily reflect an endogenously-generated Th17 response, and that functions of Th17 responses are contingent on the experimental conditions in which they are generated. |
format | Online Article Text |
id | pubmed-3778003 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-37780032013-09-25 The Endogenous Th17 Response in NO(2)-Promoted Allergic Airway Disease Is Dispensable for Airway Hyperresponsiveness and Distinct from Th17 Adoptive Transfer Martin, Rebecca A. Ather, Jennifer L. Daggett, Rebecca Hoyt, Laura Alcorn, John F. Suratt, Benjamin T. Weiss, Daniel J. Lundblad, Lennart K. A. Poynter, Matthew E. PLoS One Research Article Severe, glucocorticoid-resistant asthma comprises 5-7% of patients with asthma. IL-17 is a biomarker of severe asthma, and the adoptive transfer of Th17 cells in mice is sufficient to induce glucocorticoid-resistant allergic airway disease. Nitrogen dioxide (NO(2)) is an environmental toxin that correlates with asthma severity, exacerbation, and risk of adverse outcomes. Mice that are allergically sensitized to the antigen ovalbumin by exposure to NO(2) exhibit a mixed Th2/Th17 adaptive immune response and eosinophil and neutrophil recruitment to the airway following antigen challenge, a phenotype reminiscent of severe clinical asthma. Because IL-1 receptor (IL-1R) signaling is critical in the generation of the Th17 response in vivo, we hypothesized that the IL-1R/Th17 axis contributes to pulmonary inflammation and airway hyperresponsiveness (AHR) in NO(2)-promoted allergic airway disease and manifests in glucocorticoid-resistant cytokine production. IL-17A neutralization at the time of antigen challenge or genetic deficiency in IL-1R resulted in decreased neutrophil recruitment to the airway following antigen challenge but did not protect against the development of AHR. Instead, IL-1R-/- mice developed exacerbated AHR compared to WT mice. Lung cells from NO(2)-allergically inflamed mice that were treated in vitro with dexamethasone (Dex) during antigen restimulation exhibited reduced Th17 cytokine production, whereas Th17 cytokine production by lung cells from recipient mice of in vitro Th17-polarized OTII T-cells was resistant to Dex. These results demonstrate that the IL-1R/Th17 axis does not contribute to AHR development in NO(2)-promoted allergic airway disease, that Th17 adoptive transfer does not necessarily reflect an endogenously-generated Th17 response, and that functions of Th17 responses are contingent on the experimental conditions in which they are generated. Public Library of Science 2013-09-19 /pmc/articles/PMC3778003/ /pubmed/24069338 http://dx.doi.org/10.1371/journal.pone.0074730 Text en © 2013 Martin et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Martin, Rebecca A. Ather, Jennifer L. Daggett, Rebecca Hoyt, Laura Alcorn, John F. Suratt, Benjamin T. Weiss, Daniel J. Lundblad, Lennart K. A. Poynter, Matthew E. The Endogenous Th17 Response in NO(2)-Promoted Allergic Airway Disease Is Dispensable for Airway Hyperresponsiveness and Distinct from Th17 Adoptive Transfer |
title | The Endogenous Th17 Response in NO(2)-Promoted Allergic Airway Disease Is Dispensable for Airway Hyperresponsiveness and Distinct from Th17 Adoptive Transfer |
title_full | The Endogenous Th17 Response in NO(2)-Promoted Allergic Airway Disease Is Dispensable for Airway Hyperresponsiveness and Distinct from Th17 Adoptive Transfer |
title_fullStr | The Endogenous Th17 Response in NO(2)-Promoted Allergic Airway Disease Is Dispensable for Airway Hyperresponsiveness and Distinct from Th17 Adoptive Transfer |
title_full_unstemmed | The Endogenous Th17 Response in NO(2)-Promoted Allergic Airway Disease Is Dispensable for Airway Hyperresponsiveness and Distinct from Th17 Adoptive Transfer |
title_short | The Endogenous Th17 Response in NO(2)-Promoted Allergic Airway Disease Is Dispensable for Airway Hyperresponsiveness and Distinct from Th17 Adoptive Transfer |
title_sort | endogenous th17 response in no(2)-promoted allergic airway disease is dispensable for airway hyperresponsiveness and distinct from th17 adoptive transfer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778003/ https://www.ncbi.nlm.nih.gov/pubmed/24069338 http://dx.doi.org/10.1371/journal.pone.0074730 |
work_keys_str_mv | AT martinrebeccaa theendogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer AT atherjenniferl theendogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer AT daggettrebecca theendogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer AT hoytlaura theendogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer AT alcornjohnf theendogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer AT surattbenjamint theendogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer AT weissdanielj theendogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer AT lundbladlennartka theendogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer AT poyntermatthewe theendogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer AT martinrebeccaa endogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer AT atherjenniferl endogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer AT daggettrebecca endogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer AT hoytlaura endogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer AT alcornjohnf endogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer AT surattbenjamint endogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer AT weissdanielj endogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer AT lundbladlennartka endogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer AT poyntermatthewe endogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer |